Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The epidermal growth factor receptor (EGFR) gene produces multiple mRNA variants, including full-length (isoform a) and truncated forms (b, c, d), as well as a mutant form (EGFRvIII).
• The expression patterns of these EGFR isoforms in adult diffuse gliomas are not well understood.

Purpose of the Study:

• To investigate the expression of various EGFR isoforms and the EGFR gene in adult diffuse gliomas.
• To correlate EGFR expression patterns with histological features and patient outcomes.

Main Methods:

• Immunohistochemistry using antibodies against extracellular and intracellular EGFR domains.
• RT-PCR to detect mRNA expression of EGFR variants (v1-v4) and EGFRvIII.
• Fluorescent in situ hybridization (FISH) for EGFR gene amplification.

Main Results:

• EGFR variants v1-v4 mRNA were expressed in all gliomas, with higher levels in glioblastomas.
• EGFR gene amplification was observed exclusively in glioblastomas.
• Stronger staining with extracellular domain antibodies compared to intracellular domain antibodies was noted.
• High levels of EGFRv1, v2, v3, and v4 mRNA, EGFR amplification, and strong intracellular antibody staining correlated with glioblastoma histology and poorer patient outcomes.

Conclusions:

• Diffuse gliomas express a variety of EGFR isoforms beyond the full-length and EGFRvIII forms.
• The diverse expression of EGFR variants may account for discrepancies in immunohistochemical findings in the literature.
• Understanding these EGFR expression patterns has potential implications for glioma treatment strategies.